Asia Digital Health Updates: Hong Kong respiratory rate monitoring gets 510(k) clearance, South Korea AI radiology expansion, and Singapore-Vietnam preventive healthcare cooperation.

Latest Developments in Asian Digital Health and AI in Medicine: Regulatory Approvals, Technology Integration, and Capital Inflows

Introduction

In June 2026, the Asian digital health sector is experiencing a dual wave of regulatory breakthroughs and technology deployment. From remote physiological monitoring in Hong Kong to AI integration in radiology in South Korea, and cross-border preventive healthcare collaboration between Singapore and Vietnam, these developments indicate that Asia is becoming a key engine of global medical technology innovation. This article compiles several recent significant advancements and analyzes their impact on the industry landscape.

Industry Background

The global digital health market continues to expand, with remote monitoring, AI diagnostics, and preventive care emerging as core growth drivers. The FDA's 510(k) clearance has opened the market for wireless monitoring devices, while hospital systems in Europe and Asia are accelerating AI integration. Against this backdrop, Asian companies are noticeably speeding up their internationalization.

Key Developments

#### 1. Hong Kong's PanopticAI: FDA Clearance for Contactless Respiratory Rate Monitoring

Hong Kong-based tech startup PanopticAI announced that the respiratory rate measurement function of its Vital Signs mobile application has received FDA 510(k) Class II clearance. This is the company's second FDA approval, following its contactless pulse monitoring. The app uses a smartphone camera, remote photoplethysmography, and motion analysis algorithms to measure pulse, respiratory rate, blood pressure, atrial fibrillation, and the risk of elevated blood glucose and lipids, without external sensors or wearable devices. PanopticAI's technology originates from research at the Hong Kong University of Science and Technology's School of Engineering and is suitable for both clinical and home settings. This approval marks the transition of contactless physiological monitoring from concept to practice, potentially revolutionizing remote patient monitoring models.

#### 2. South Korea's Coreline Soft and Germany's Mint Medical: AI Integration Supports Lung Cancer Screening

South Korean medical AI company Coreline Soft has partnered with German software company Mint Medical to integrate Coreline Soft's chest CT analysis AI into the Mint Lesion radiology software. The integration includes AI-driven lung nodule detection, multi-disease chest CT analysis, structured reporting, longitudinal nodule tracking, and multi-site reading management. Coreline Soft is already the exclusive technology partner for Germany's national lung cancer screening project HANSE, and this collaboration will further promote the large-scale application of AI in early lung cancer screening. This case demonstrates how AI algorithms can seamlessly integrate with existing workflows to enhance radiologist efficiency.

#### 3. South Korea's AIRS Medical: Strategic Investment Accelerates MRI AI GlobalizationSeoul-based AIRS Medical announced a strategic growth investment from TA Associates, with the specific amount undisclosed. The funds will be used for global expansion, AI-driven radiology technology development, and product innovation. The company offers SwiftMR (AI-accelerated MRI image enhancement) and SwiftSight (MRI quantification and structured reporting platform), covering the entire process from image acquisition to clinical interpretation. Founded in 2018, AIRS Medical has served over 1,700 medical institutions in more than 40 countries. This investment reflects the capital market's confidence in AI medical imaging solutions, especially tools that can directly improve imaging speed and diagnostic quality.

#### 4. Singapore’s QuantumTX and Vietnam’s Kaopiz: AI Preventive Healthcare Collaboration

Singapore health tech company QuantumTX and Vietnamese software company Kaopiz have signed a memorandum to jointly develop preventive healthcare solutions using AI, IoT engineering, and health data platforms. Under the agreement, Kaopiz will develop and maintain software for QuantumTX’s IoT medical device ecosystem, including device control, embedded system integration, AI health data analysis, mobile applications, cloud-based remote device management, and real-time monitoring. This collaboration focuses on healthcare and rehabilitation use cases, reflecting the trend of cross-border collaboration in digital health among Southeast Asian countries.

Market Impact

These developments have multiple implications for the healthcare industry:

• Regulatory Breakthrough: PanopticAI’s consecutive FDA approvals indicate that contactless physiological monitoring technology is gaining recognition from mainstream regulators, paving the way for similar devices to enter the U.S. market.
• AI Workflow Integration: The cases of Coreline Soft and AIRS Medical show that AI is no longer a standalone tool but is deeply embedded in radiology software and hospital information systems, driving the transformation of "AI as infrastructure."
• Capital Inflow: AIRS Medical’s strategic investment shows that investors are optimistic about the commercialization prospects of AI medical imaging, especially in the MRI field, where acceleration time and image quality optimization provide clear cost benefits.
• Preventive Healthcare Collaboration: The partnership between QuantumTX and Kaopiz highlights regional technological complementarity within Asia: Singapore’s algorithm and platform capabilities combined with Vietnam’s software development resources, targeting preventive healthcare needs in emerging markets.

Challenges and Risks

• Despite the optimistic outlook, these technologies still face challenges:- Clinical Validation: The accuracy and reliability of contactless monitoring still require support from large-scale clinical studies. FDA 510(k) is based on substantial equivalence, and long-term real-world data are still being collected.
• Data Privacy: Camera-based physiological monitoring involves facial video data and must comply with privacy regulations of different countries (e.g., GDPR, HIPAA).
• Integration Barriers: The integration of AI with existing hospital IT systems is not straightforward; the collaboration model between Coreline Soft and Mint Medical requires customized interfaces and training.
• Market Acceptance: Building trust in AI-assisted diagnostics among doctors and patients takes time, especially in culturally conservative medical environments.